Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R H Rousell

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Annals of Internal Medicine|January 1, 1982
Immune globulin for intravenous infusionR H Rousell
The Journal of Hospital Infection|August 1, 1988
Clinical safety of intravenous immune globulin and freedom from transmission of viral diseaseR H Rousell
The Journal of Infection|July 1, 1987
A new intravenous immunoglobulin in adult and childhood idiopathic thrombocytopenic purpura: a reviewR H Rousell
Lancet (London, England)|June 14, 1986
Heat treatment of factor VIII concentrateR H Rousell
Anaesthesia|January 1, 1980
Reactions to HaemaccelW Bogie, R H Rousell
Seminars in Hematology|April 1, 1991
A summary of the world-wide clinical investigations of recombinant factor VIIIR S Schwartz, R H Rousell
Transfusion|March 1, 1989
The pharmacology of a new pasteurized antihemophilic factor concentrate derived from human blood plasmaR H Rousell, C K Kasper, R S Schwartz
Lancet (London, England)|April 7, 1979
Units for immunoreactive trypsinT P Wood, M R Redshaw, R H Rousell
Vox Sanguinis|January 1, 1988
Non-A non-B hepatitis and the safety of intravenous immune globulin, pH 4.2: a retrospective survey. Preliminary communicationR H Rousell, R A Good, B Pirofsky, et al.
Vox Sanguinis|January 1, 1991
Prospective study on the hepatitis safety of intravenous immunoglobulin, pH 4.25R H Rousell, M D Budinger, B Pirofsky, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Annals of Internal Medicine|January 1, 1982
Immune globulin for intravenous infusionR H Rousell
The Journal of Hospital Infection|August 1, 1988
Clinical safety of intravenous immune globulin and freedom from transmission of viral diseaseR H Rousell
The Journal of Infection|July 1, 1987
A new intravenous immunoglobulin in adult and childhood idiopathic thrombocytopenic purpura: a reviewR H Rousell
Lancet (London, England)|June 14, 1986
Heat treatment of factor VIII concentrateR H Rousell
Anaesthesia|January 1, 1980
Reactions to HaemaccelW Bogie, R H Rousell
Seminars in Hematology|April 1, 1991
A summary of the world-wide clinical investigations of recombinant factor VIIIR S Schwartz, R H Rousell
Transfusion|March 1, 1989
The pharmacology of a new pasteurized antihemophilic factor concentrate derived from human blood plasmaR H Rousell, C K Kasper, R S Schwartz
Lancet (London, England)|April 7, 1979
Units for immunoreactive trypsinT P Wood, M R Redshaw, R H Rousell
Vox Sanguinis|January 1, 1988
Non-A non-B hepatitis and the safety of intravenous immune globulin, pH 4.2: a retrospective survey. Preliminary communicationR H Rousell, R A Good, B Pirofsky, et al.
Vox Sanguinis|January 1, 1991
Prospective study on the hepatitis safety of intravenous immunoglobulin, pH 4.25R H Rousell, M D Budinger, B Pirofsky, et al.
Pageof 2